Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients
Yıl: 2017 Cilt: 21 Sayı: 3 Sayfa Aralığı: 603 - 611 Metin Dili: İngilizce DOI: 10.12991/marupj.323286 İndeks Tarihi: 18-07-2019
Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients
Öz: Drug related-problems pose additional worse outcomes incancer patients treated with chemotherapy. A vital role of theclinical pharmacist is the detection and prevention of drug-related problems. The provision of patient education is animportant step to reduce and prevent drug-related problemsduring chemotherapy administration. The objective of thisstudy was to assess the occurrence of drug-related problemsand the importance of effective provision of patient educationand appropriate recommendations by the clinical pharmacistin reducing and solving of these problems in diabetic patientssuffering from cancer.A prospective study carried out on 50 diabetic patients asa single group with new diagnosis of diverse cancer typeseligible for chemotherapy adminitration recruited betweenSeptember 2014 and April 2015 at the oncology unit in oneof the Teaching and Research Hospital (Istanbul-Turkey).Drug-related problems were evaluated, and proper patienteducation alongside pharmacist recommendation regardingchemotherapy was provided during the required chemotherapyprotocol schedule. (n=65) of the drug-related problems werecontributed to inappropriate IV fluid selection; (n=33) wereattributed to low drug dose prescribed, and (n=30) to highdrug dose prescribed. Drug-related problems totally solveddue to clinical pharmacist recommendations were 69.57%(n=80). There was a significant increase in the occurrence ofpaleness (P=0.0001); urinary frequency (P=0.003); loss ofappetite (P=0.0001), nausea (P=0.0001), vomiting (P=0.0001);and numbness (P=0.0001). A significant decrease in theoccurrence and severity of chemotherapy-related adverseeffects was observed as a mild urinary frequency (P=0.0001)and mild vomiting (P=0.0001) after the clinical pharmacistrecommendations and provision of patient education.Results of this study revealed that diabetic cancer patients aredefinitly prone to the occurrence of drug-related problemsand adverse drug reactions. Clinical pharmacist is expected toprovide a well-defined education and care to those patients andthe outcomes of pharmacist recommendations may diminishand prevent many drug-related problems and adverse drugreactions and by this, influence patients’ desire to complete thecourse of chemotherapy.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer 2009;16:1103-23.
- Pharmaceutical Care Network Europe. DRP-Classification V6.2. 2010. http://www.pcne.org/upload/files/11_PCNE_ classification_V6.2.pdf. Accessed date: 8 March 2017.
- Ruths S, Viktil KK, Blix HS. Classification of drug-related problems. Tidsskr Nor Laegeforen 2007; 127: 3073-6.
- Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM; HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890-6.
- Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, Rasmussen M. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci 2009 ;31:216-23.
- Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: Systematic review. Clin Epidemiol 2009;1:75- 92.
- Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004;57:121- 6.
- Jamali AN, Aqil M, Alam MS, Pillai KK, Kapur P. A pharmacovigilance study on patients of bronchial asthma in a teaching hospital. J Pharm Bioallied Sci 2010;2:333-6.
- Ouyang Z, Peng D, Dhakal DP. Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma. Oncol Lett 2013;5:1736-1740.
- Cosentino M, Leoni O, Oria C, Michielotto D, Massimo E, Lecchini S, Frigo G. Hospital-based survey of doctors’ attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence. Pharmacoepidemiol Drug Saf 1999;8 Suppl 1:S27-35.
- van Grootheest K, de Jong-van den Berg L. Patients’ role in reporting adverse drug reactions. Expert Opin Drug Saf 2004;3:363-8.
- Aranda S, Jefford M, Yates P, Gough K, Seymour J, Francis P, Baravelli C, Breen S, Schofield P. Impact of a novel nurseled prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results from a randomised, controlled trial. Ann Oncol 2012;23:222-31.
- Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002;95:155-63.
- Kayl AE, Meyers CA. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol 2006;18: 24-8.
- Hadder Akram AbdulRazzaq. Prediction of uncontrolled dyslipidemia of cardiac patients and the adverse effect od pharmaceutical excipients. Universiti Sains Malaysia (USM), doctor of Philosophy (PhD) Thesis, 2013, Penang, Malaysia (Supervisor; Syed Azhar Syed Sulaiman).
- Sisay EA, Engidawork E, Yesuf TA, Ketema EB. Drug Related Problems in Chemotherapy of Cancer Patients. J Cancer Sci Ther 2015; 7: 055-9.
- Ogbonna BO, Ezenduka CC, Opara CA, Ahara LG. Drug therapy problems in patients with Type-2 Diabetes in a tertiary hospital in Nigeria. IJIRD 2014; 3: 494-502.
- Hamza NA, Abdou Sallam S, El-Nimr NA. Rates and types of prescribing errors and related ınterventions in oncology. Int J Curr Microbiol App Sci 2013; 2: 435-45.
- Kuo G, Touchette D, Marinac J. Drug errors and related interventions reported by United States clinical pharmacists: The American college of clinical pharmacy practice-based research network medication error detection, amelioration and prevention study. Pharmacother 2013;33: 253-65.
- Jaehde U, Liekweg A, Simons S, Westfeld M. Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008;30:161-8.
- Slama C, Jerome J, Jacquot C, Bonan B. Prescription errors with cytotoxic drugs and the inadequacy of existing classifications. Pharm World Sci 2005 ;27:339-43.
- Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, Wu SC. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr 2012;54:168-74.
- Bob W, Ines K. Development of an evidence-based checklist for the detection of drug-related problems in type 2 diabetes mellitus. Pharm World Sci 2009; 31:580–95.
- Viktil KK, Blix HS, Moger TA, Reikvam A.Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63:187-95.
- Feyer P, Kleeberg UR, Steingräber M, Günther W, Behrens M.Frequency of side effects in outpatient cancer care and their influence on patient satisfaction—a prospective survey using the PASQOC questionnaire. Support Care Cancer 2008; 16:567–75.
- Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
- Aslam MS, Naveed S, Ahmed A, Abbas Z, Gull I, Athar MA. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. J Cancer Ther 2014; 5: 817-22.
- Atkin PA, Veitch PC, Veitch EM, Ogle SJ. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999;14:141-52.
- Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 2004; 13: 83-7.
- Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006;54:1516-23.
- Chan H-K, Ismail S. Side effects of chemotherapy among cancer patients in a Malaysian General Hospital: Experiences, perceptions and ınformational needs from clinical pharmacists. Asian Pac J Cancer Prev 2014; 15: 5305-9.
- Baniasadi S, Habibi M, Haghgoo R, Karimi Gamishan M, Dabaghzadeh F, Farasatinasab M, Farsaei S, Gharekhani A, Kafi H, Karimzadeh I, Kharazmkia A, Najmeddin F, Nikvarz N, Oghazian MB, Rezaee H, Sadeghi K, Tafazzoli A, Shahsavari N, Fahimi F. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res 2014;13:291-7.
- Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002;95:155-63.
| APA | IZZETTİN F, AL-TAİE A, SANCAR M, Aliustaoglu M (2017). Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. , 603 - 611. 10.12991/marupj.323286 |
| Chicago | IZZETTİN Fikret V.,AL-TAİE Anmar,SANCAR MESUT,Aliustaoglu Mehmet Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. (2017): 603 - 611. 10.12991/marupj.323286 |
| MLA | IZZETTİN Fikret V.,AL-TAİE Anmar,SANCAR MESUT,Aliustaoglu Mehmet Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. , 2017, ss.603 - 611. 10.12991/marupj.323286 |
| AMA | IZZETTİN F,AL-TAİE A,SANCAR M,Aliustaoglu M Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. . 2017; 603 - 611. 10.12991/marupj.323286 |
| Vancouver | IZZETTİN F,AL-TAİE A,SANCAR M,Aliustaoglu M Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. . 2017; 603 - 611. 10.12991/marupj.323286 |
| IEEE | IZZETTİN F,AL-TAİE A,SANCAR M,Aliustaoglu M "Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients." , ss.603 - 611, 2017. 10.12991/marupj.323286 |
| ISNAD | IZZETTİN, Fikret V. vd. "Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients". (2017), 603-611. https://doi.org/10.12991/marupj.323286 |
| APA | IZZETTİN F, AL-TAİE A, SANCAR M, Aliustaoglu M (2017). Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. Marmara Pharmaceutical Journal, 21(3), 603 - 611. 10.12991/marupj.323286 |
| Chicago | IZZETTİN Fikret V.,AL-TAİE Anmar,SANCAR MESUT,Aliustaoglu Mehmet Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. Marmara Pharmaceutical Journal 21, no.3 (2017): 603 - 611. 10.12991/marupj.323286 |
| MLA | IZZETTİN Fikret V.,AL-TAİE Anmar,SANCAR MESUT,Aliustaoglu Mehmet Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. Marmara Pharmaceutical Journal, vol.21, no.3, 2017, ss.603 - 611. 10.12991/marupj.323286 |
| AMA | IZZETTİN F,AL-TAİE A,SANCAR M,Aliustaoglu M Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. Marmara Pharmaceutical Journal. 2017; 21(3): 603 - 611. 10.12991/marupj.323286 |
| Vancouver | IZZETTİN F,AL-TAİE A,SANCAR M,Aliustaoglu M Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients. Marmara Pharmaceutical Journal. 2017; 21(3): 603 - 611. 10.12991/marupj.323286 |
| IEEE | IZZETTİN F,AL-TAİE A,SANCAR M,Aliustaoglu M "Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients." Marmara Pharmaceutical Journal, 21, ss.603 - 611, 2017. 10.12991/marupj.323286 |
| ISNAD | IZZETTİN, Fikret V. vd. "Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients". Marmara Pharmaceutical Journal 21/3 (2017), 603-611. https://doi.org/10.12991/marupj.323286 |
